Plain-English translation of NCT05963568 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Stroke research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a medication called ®, which combines five different medicines into two capsules taken once daily. Researchers want to see if this single daily pill can better reduce the risk of future strokes and heart problems compared to the usual way doctors prescribe multiple separate medications. The trial will follow 1,000 stroke patients in Ghana for 24 months.
Many stroke survivors struggle to remember to take multiple pills each day, which means they miss doses and their risk of a second stroke goes up. This medication is designed to make treatment simpler—by combining five essential medicines into one pill—so that patients are more likely to take it as prescribed and stay protected.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to either take the new combination pill (two capsules once daily) or continue with your usual stroke prevention medicines as your doctor normally prescribes them. Both groups will be followed for 24 months with regular check-ins to monitor your health, blood pressure, cholesterol, and overall recovery. Your doctors will track whether you're taking your medication and how well you're doing to prevent another stroke.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
Benin
Ghana
Nigeria
Tanzania